Daniel T Scavilla
CIK 1642439 · Lihat di SEC EDGAR ↗
Orang Dalam
Pengajuan SEC Pertama: 15 Mei 2015 · Terbaru: 26 Mei 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
0 beli (P)
0 jual (S)
Bersih:
$0
+ 45 transaksi non-pasar di bawah
12 bulan terakhir, berdasarkan transaksi yang ditunjukkan di bawah ini
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
45 pengajuan lain disembunyikan
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 21 Nov. 2024 | GMED | S 10b5-1 | 130.000 | $85,00 | $11.050.000 | 0 Langsung | -100,00% | Dilepas | 3,8% (harga per 2026-08-19) |
| 6 Nov. 2024 | GMED | S 10b5-1 | 60.000 | $80,02 | $4.801.200 | 0 Langsung | -100,00% | Dilepas | 10,3% (harga per 2026-08-19) |
| 2 Juli 2021 | GMED | S 10b5-1 | 400 | $78,97 | $31.588 | 0 Langsung | -100,00% | Dilepas | 11,7% (harga per 2026-08-19) |
| 2 Juli 2021 | GMED | S 10b5-1 | 99.600 | $78,41 | $7.809.636 | 400 Langsung | -99,60% | Dilepas | 12,5% (harga per 2026-08-19) |
| 21 Mei 2020 | GMED | S 10b5-1 | 100.000 | $55,09 | $5.509.000 | 0 Langsung | -100,00% | Dilepas | 60,2% (harga per 2026-08-19) |
| 10 April 2018 | GMED | S 10b5-1 | 31.250 | $50,00 | $1.562.500 | 0 Langsung | -100,00% | Dilepas | 76,5% (harga per 2026-08-19) |
| 10 April 2018 | GMED | S 10b5-1 | 50.540 | $50,00 | $2.527.000 | 0 Langsung | -100,00% | Dilepas | 76,5% (harga per 2026-08-19) |
| 9 April 2018 | GMED | S 10b5-1 | 18.210 | $50,00 | $910.500 | 0 Langsung | -100,00% | Dilepas | 76,5% (harga per 2026-08-19) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 11 Maret 2026 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (3.555) | — | — | 3.555 | Diakuisisi |
| 4 Maret 2026 | XRAY | Stock Option (Right to Buy) | Common Stock (2.066.600) | $15,46 | 4 Maret 2036 | 2.066.600 | Diakuisisi |
| 8 Agu 2025 | XRAY | Stock Option (Right to Buy) | Common Stock (1.102.600) | $12,96 | 8 Agu 2035 | 1.102.600 | Diakuisisi |
| 23 Jan. 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (140.000) | $92,42 | 23 Jan. 2035 | 140.000 | Diakuisisi |
| 21 Nov. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (80.000) | $43,58 | 22 Jan. 2029 | 80.000 | Dilepas |
| 21 Nov. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (50.000) | $43,77 | 22 Jan. 2028 | 50.000 | Dilepas |
| 6 Nov. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (30.000) | $43,77 | 22 Jan. 2028 | 30.000 | Diakuisisi |
| 6 Nov. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (30.000) | $26,27 | 30 Jan. 2027 | 30.000 | Diakuisisi |
| 26 Jan. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (140.000) | $53,75 | 26 Jan. 2034 | 140.000 | Diakuisisi |
| 10 Okt. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (10.000) | $53,02 | 1 Sep. 2033 | 10.000 | Diakuisisi |
| 26 Jan. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100.000) | $75,18 | 26 Jan. 2033 | 100.000 | Diakuisisi |
| 21 April 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (60.000) | $79,00 | 21 April 2032 | 60.000 | Diakuisisi |
| 27 Jan. 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40.000) | $63,68 | 27 Jan. 2032 | 40.000 | Diakuisisi |
| 2 Juli 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (50.000) | $26,27 | 30 Jan. 2027 | 50.000 | Dilepas |
| 2 Juli 2021 | GMED | Stock Option (Right to buy Class A Common Stock) | Class A Common Stock (50.000) | $25,52 | 25 Jan. 2026 | 50.000 | Dilepas |
| 14 Jan. 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (50.000) | $65,05 | 14 Jan. 2031 | 50.000 | Diakuisisi |
| 21 Mei 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (68.750) | $25,52 | 25 Jan. 2026 | 68.750 | Dilepas |
| 21 Mei 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (31.250) | $25,40 | 8 April 2025 | 31.250 | Dilepas |
| 22 Jan. 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (80.000) | $53,27 | 22 Jan. 2030 | 80.000 | Diakuisisi |
| 22 Jan. 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (80.000) | $43,58 | 22 Jan. 2029 | 80.000 | Diakuisisi |
| 10 April 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (31.250) | $25,52 | 25 Jan. 2026 | 31.250 | Dilepas |
| 10 April 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (50.540) | $25,40 | 8 April 2025 | 50.540 | Dilepas |
| 9 April 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (18.210) | $25,40 | 8 April 2025 | 18.210 | Dilepas |
| 22 Jan. 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (80.000) | $43,77 | 22 Jan. 2028 | 80.000 | Diakuisisi |
| 30 Jan. 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (80.000) | $26,27 | 30 Jan. 2027 | 80.000 | Diakuisisi |
| 25 Jan. 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (150.000) | $25,52 | 25 Jan. 2026 | 150.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 2 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
XRAY
CEO| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $431.753 | $1.079.315 | $3.484.488 | $3.221.523 | $437.150 | — | $105.910 | $8.760.139 |
GMED
CEO| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $284.616 | — | — | — | — | — | $25.678 | $5.316.939 |
| 2024 | $481.077 | — | — | $2.936.886 | $1.404.150 | — | $36.547 | $4.858.660 |
| 2023 | $463.500 | $150.000 | — | $2.896.394 | $1.021.500 | — | $32.980 | $4.564.374 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.